Potential threats to HIV care and fallout over the next four years, according to Jose Abrigo, Esq., HIV project director at ...

Much of the association between trauma and suicide risk among university students can be explained by shame, a new study ...

Becky Kamowitz was appointed executive director of The Skin Cancer Foundation in January 2025. She talks about organization’s ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

A panelist discusses how she navigates the economic challenges of neurokinin-targeted therapies by working with insurance providers and patient assistance programs while advocating for expanded access ...

This follows the company’s recent earnings call, where executives discussed the organization’s growth and future plans, ...

The new biosimilar, Celltrion’s Avtozma, was approved in both IV and subcutaneous forms to treat inflammatory conditions such as arthritis.

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

A panelist discusses how their institution evaluates biosimilars for formulary inclusion through a systematic review process ...

The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...